Human FRS2 Antibody Summary
Asn121-Asn449
Accession # Q8WU20
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
FRS2 in Human Liver and Liver Cancer Tissue. FRS2 was detected in immersion fixed paraffin-embedded sections of human normal liver and liver cancer tissue using Sheep Anti-Human FRS2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF4069) at 1 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Sheep HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS019) and counterstained with hematoxylin (blue). Specific staining was localized to cancer cell cytoplasm and cell membranes. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: FRS2
FRS2 (FGFR substrate 2; also known as SNT and FRS2-alpha ) is a 70‑90 kDa member of the FRS family of lipid-anchored docking proteins. It is an intermediary between FGF and TRK receptors and their Ras/MAPK signaling cascades. Human FRS2 is 512 amino acids (aa) in length. It contains a membrane-anchoring myristoylation signal (aa 1‑6), a PTB domain that interacts with FGF and NGF receptors (aa 13‑115), and a C-terminal Tyr-rich region that serves as a docking site for Grb2 and Shp2 (aa 196‑471). One splice form shows a deletion of the C-terminal four amino acids. Over aa 121‑449, human FRS2 is 99% and 94% aa identical to canine and mouse FRS2, respectively.
Product Datasheets
Citations for Human FRS2 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
3
Citations: Showing 1 - 3
Filter your results:
Filter by:
-
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models
Neoplasia, 2016-12-15;19(1):35-42.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy
Authors: Kenshi Higashi, Yoshihisa Yamada, Shingo Minatoguchi, Shinya Baba, Masamitsu Iwasa, Hiromitsu Kanamori et al.
American Journal of Physiology-Heart and Circulatory Physiology
-
Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models
Authors: Osamu Tohyama, Junji Matsui, Kotaro Kodama, Naoko Hata-Sugi, Takayuki Kimura, Kiyoshi Okamoto et al.
Journal of Thyroid Research
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human FRS2 Antibody
There are currently no reviews for this product. Be the first to review Human FRS2 Antibody and earn rewards!
Have you used Human FRS2 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image